Skip to main content

Research from Wednesday’s close · next update overnight after Thursday’s close

Account
Skip to search and all names

Radar

Research Scores and source-backed evidence for the Liquid 100.

What these mean
Research score
The published research view as one number. 50 is balanced; higher leans Bullish, lower leans Bearish.
Bullish, Neutral, Bearish
Bullish, Neutral and Bearish are set by the research from its score, not by this page: 65 and above is Bullish, 45 to 64 Neutral, 44 and below Bearish. Archived simulated sessions use 60 and above for Bullish and 40 and below for Bearish.
Confidence
How well the evidence supports the view, not which way it points: Sagehood research is asked to keep it no higher than its most confident specialist, and lower when the specialists disagree or much of the evidence is weak. It is not a calibrated probability that the view is right.
100 of 100 names0 Bullish72 Neutral28 BearishLiquid 100 research universe · 50 is balanced

Accepted research ·

Point-in-time
Research details: evidence and break conditions
  • MOConfidence 70
    Score64Neutral

    Altria's cash conversion supports a constructive view, because $23,517 million of trailing-twelve-month revenue at a 47.0% operating margin produced $9,071 million of free cash flow. The unresolved risk is flat growth, since revenue rose only 0.5%.

    Break condition: A later reading showing trailing-twelve-month revenue growth below the 6.1% sector revenue-growth median would break the growth claim.

  • MNSTConfidence 50
    Score63Neutral

    Monster's cash-generative brand supports a constructive view, because $9,219 million of trailing-twelve-month revenue grew 20.4% at a 29.2% operating margin. The unresolved risk is valuation, since the peer-implied median of 28.87 sits 40.8% below the 48.75 close.

    Break condition: A later reading showing trailing-twelve-month revenue growth below the 6.1% sector revenue-growth median would break the growth claim.

  • GENConfidence 60
    Score62Neutral

    GEN looks neutral because trailing-twelve-month revenue grew 16.9% with a 41.8% operating margin, yet price sits 27.3% above its 200-day average with 14-day RSI at 75.3. The unresolved risk is the −21.6% 90-day channel slope against the $70.20 base fair value.

    Break condition: A later reading of trailing-twelve-month revenue growth below the 21.8% sector revenue-growth median would break the growth claim.

How often break conditions happened: across 12 research runs, 52 of 53 price-level break conditions (98%) were crossed within 20 sessions; 157 are still open. A crossing means the stated condition happened, not that the view was wrong about direction.

All names

Results update as you type. Enter opens an exact match or the only result.

Skip to results

100 of 100 researched · 2026-11-04 · Top 100 liquid names

Sort by:

Showing 1 to 12 of 100 names

Results

Research Scores and closing prices · research session 2026-11-04 · closes as the research recorded them

MO

Altria

Asset Price
$78.01
Day Return
+1.39%

Research Score
Neutral
64

Altria's cash conversion supports a constructive view, because $23,517 million of trailing-twelve-month revenue at a 47.0% operating margin produced $9,071 million of free cash flow. The unresolved risk is flat growth, since revenue rose only 0.5%.

Break condition: A later reading showing trailing-twelve-month revenue growth below the 6.1% sector revenue-growth median would break the growth claim.

MO dates and sources: Recorded close · Dates & sources

Research Score session 2026-11-04 · 8 accepted specialist outputs · Evidence base: One committee conclusion · Close 2026-11-04, as the research recorded it · Accepted research

MNST

Monster Beverage

Asset Price
$48.75
Day Return
+3.33%

Research Score
Neutral
63

Monster's cash-generative brand supports a constructive view, because $9,219 million of trailing-twelve-month revenue grew 20.4% at a 29.2% operating margin. The unresolved risk is valuation, since the peer-implied median of 28.87 sits 40.8% below the 48.75 close.

Break condition: A later reading showing trailing-twelve-month revenue growth below the 6.1% sector revenue-growth median would break the growth claim.

MNST dates and sources: Recorded close · Dates & sources

Research Score session 2026-11-04 · 8 accepted specialist outputs · Evidence base: One committee conclusion · Close 2026-11-04, as the research recorded it · Accepted research

GEN

Gen Digital

Asset Price
$30.89
Day Return
+3.97%

Research Score
Neutral
62

GEN looks neutral because trailing-twelve-month revenue grew 16.9% with a 41.8% operating margin, yet price sits 27.3% above its 200-day average with 14-day RSI at 75.3. The unresolved risk is the −21.6% 90-day channel slope against the $70.20 base fair value.

Break condition: A later reading of trailing-twelve-month revenue growth below the 21.8% sector revenue-growth median would break the growth claim.

GEN dates and sources: Recorded close · Dates & sources

Research Score session 2026-11-04 · 8 accepted specialist outputs · Evidence base: One committee conclusion · Close 2026-11-04, as the research recorded it · Accepted research

AAPL

Apple Inc.

Asset Price
$349.51
Day Return
+5.31%

Research Score
Neutral
60

Apple's quality case rests on a 33.0% trailing-twelve-month operating margin and $136,056 million of free cash flow, because margins hold well above the 22.2% sector median. The unresolved risk is valuation, since the $143.00 base fair value sits 59% below the $349.51 close.

Break condition: A later reading showing trailing-twelve-month revenue growth at or below the 21.8% sector revenue-growth median would break the growth claim.

AAPL dates and sources: Recorded close · Dates & sources

Research Score session 2026-11-04 · 8 accepted specialist outputs · Evidence base: One committee conclusion · Close 2026-11-04, as the research recorded it · Accepted research

CRM

Salesforce

Asset Price
$227.11
Day Return
+2.21%

Research Score
Neutral
60

Salesforce screens neutral because its $321.00 base fair value sits 41% above the $227.11 close on a 9.5% growth row. The unresolved risk is leverage, since net debt to EBITDA of 3.25 far exceeds the 0.55 sector median.

Break condition: A later reading of revenue growth that falls below the threshold of 4.7% would break the base case case, since that row's fair value of $256.10 sits only 13% above the close.

CRM dates and sources: Recorded close · Dates & sources

Research Score session 2026-11-04 · 8 accepted specialist outputs · Evidence base: One committee conclusion · Close 2026-11-04, as the research recorded it · Accepted research

HST

Host Hotels & Resorts

Asset Price
$26.11
Day Return
+1.28%

Research Score
Neutral
60

Host Hotels' 57.9% one-year channel slope and 4.9% revenue growth support a neutral view, because the trend is extended. The unresolved risk is mean-reversion from 22.0% above the 200-day average at a 52-week high.

Break condition: Timing evidence: a daily close below $23.99 would break the trend read, since that level sits beyond the noise band around the close.

HST dates and sources: Recorded close · Dates & sources

Research Score session 2026-11-04 · 8 accepted specialist outputs · Evidence base: One committee conclusion · Close 2026-11-04, as the research recorded it · Accepted research

KDP

Keurig Dr Pepper

Asset Price
$36.79
Day Return
+5.90%

Research Score
Neutral
60

Keurig Dr Pepper's 27.5% revenue growth and 1.38 cash conversion support a neutral view, because leverage is high. The unresolved risk is a 6.1 net-debt-to-EBITDA ratio against the 1.89 sector median.

Break condition: A later reading showing net debt to EBITDA above the 1.89 sector net-debt-to-EBITDA median would break the balance-sheet claim.

KDP dates and sources: Recorded close · Dates & sources

Research Score session 2026-11-04 · 8 accepted specialist outputs · Evidence base: One committee conclusion · Close 2026-11-04, as the research recorded it · Accepted research

MDT

Medtronic

Asset Price
$104.96
Day Return
+6.15%

Research Score
Neutral
60

Medtronic looks fairly balanced because $6,132 million of free cash flow and net debt to EBITDA of 1.99 support the franchise, while the base case prints $95.1, 9% below the $104.96 close. The unresolved risk is that the 4.5 excess move has no identified cause.

Break condition: A later reading showing net debt to EBITDA above the 1.99 sector median would break the balance-sheet read, since the current 1.99 ratio only matches it.

MDT dates and sources: Recorded close · Dates & sources

Research Score session 2026-11-04 · 8 accepted specialist outputs · Evidence base: One committee conclusion · Close 2026-11-04, as the research recorded it · Accepted research

MSFT

Microsoft

Asset Price
$555.80
Day Return
+6.68%

Research Score
Neutral
60

Microsoft's margin premium supports a graded view, because $346,445 million of trailing-twelve-month revenue at a 47.1% operating margin sits far above the 22.2% sector median. The unresolved risk is valuation, since the base case fair value of $167.8 sits 70% below the $555.8 close.

Break condition: A later reading showing trailing-twelve-month operating margin below the threshold of 22.2% would break the margin-premium claim.

$167.8 above: declined by the valuation model. See Valuation range on the stock page.

MSFT dates and sources: Recorded close · Dates & sources

Research Score session 2026-11-04 · 7 accepted specialist outputs · Evidence base: One committee conclusion · Close 2026-11-04, as the research recorded it · Accepted research

KO

The Coca-Cola Company

Asset Price
$95.80
Day Return
+1.05%

Research Score
Neutral
59

Coca-Cola looks fairly balanced because net debt to EBITDA of −0.81 and $14,282 million of free cash flow support the franchise, while the base case prints $74.1, 23% below the $95.8 close. The unresolved risk is that 13 good-news days followed by underperformance items show good news being sold.

Break condition: A later reading showing free cash flow conversion below the 0.98 sector median would break the cash-quality read, since the current 0.98 ratio only matches it.

KO dates and sources: Recorded close · Dates & sources

Research Score session 2026-11-04 · 8 accepted specialist outputs · Evidence base: One committee conclusion · Close 2026-11-04, as the research recorded it · Accepted research

BMY

Bristol Myers Squibb

Asset Price
$64.19
Day Return
+4.02%

Research Score
Neutral
58

The constructive-leaning view is driven by valuation, since the base case's $88.80 fair value sits 38% above the $64.19 close. The unresolved risk is the modest 4.2% trailing-twelve-month revenue growth, which leaves the trajectory short of the modeled value.

Break condition: A later reading showing the peer median price-to-earnings at or below the current 34.39 would break the discount claim, since the own multiple is 14.23.

BMY dates and sources: Recorded close · Dates & sources

Research Score session 2026-11-04 · 8 accepted specialist outputs · Evidence base: One committee conclusion · Close 2026-11-04, as the research recorded it · Accepted research

CCL

Carnival Corporation

Asset Price
$31.32
Day Return
+7.26%

Research Score
Neutral
58

The constructive-leaning view is driven by cash conversion, since $3,176 million of free cash flow converts at 1.01 versus the 0.68 sector median. The unresolved risk is leverage at 3.1 times operating income with 6.3% share growth.

Break condition: A later reading showing net debt to operating income above the 3.1 level already reported would break the deleveraging claim.

CCL dates and sources: Recorded close · Dates & sources

Research Score session 2026-11-04 · 8 accepted specialist outputs · Evidence base: One committee conclusion · Close 2026-11-04, as the research recorded it · Accepted research

Page 1 of 9

Bullish, Neutral and Bearish are set by the research from its score, not by this page: 65 and above is Bullish, 45 to 64 Neutral, 44 and below Bearish. Archived simulated sessions use 60 and above for Bullish and 40 and below for Bearish. Each research session keeps its own scores and conclusions.

Accepted research

Research dated 2026-11-04.

How this research was made

This research is AI-generated and is not investment advice.

Research date
2026-11-04
Today's accepted research notes100 namesThe case and main risk for every name, in one list

As of 2026-11-04 · Research only · accepted publication

Sagehood research is for general information. It is not individualized investment advice or a recommendation to buy or sell any security.

Research Scores are research views, not trade signals. The earlier method’s archived signal feed covers 2025-05-07 to 2026-04-09.

Radar — Top 100 | Sagehood